Literature DB >> 7605360

Increased number of high sensitive platelets in hypercholesterolemia, cardiovascular diseases, and after incubation with cholesterol.

C Opper1, C Clement, H Schwarz, J Krappe, A Steinmetz, J Schneider, W Wesemann.   

Abstract

The number of low density platelets was found to be increased in patients with hypercholesterolemia, as compared with the number in controls. The percentage increase of the low density platelet subpopulation was even more pronounced in patients with hypercholesterolemia when compared with that in patients suffering from myocardial infarction or angina. In vitro studies with control platelets incubated with cholesterol rich liposomes showed also an increase in the subpopulation of low density platelets. After incubation of control platelets with cholesterol rich liposomes, a higher membrane anisotropy and a higher cholesterol to phospholipid (C/P) molar ratio of the plasma membrane were found. Furthermore, cholesterol-enriched platelets were more sensitive upon thrombin stimulation. The results suggest that a shift of platelet subpopulations to a higher number of low density platelets could be caused by either the level of plasma cholesterol or an in-vitro incubation with cholesterol rich liposomes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7605360     DOI: 10.1016/0021-9150(94)05448-r

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  17 in total

Review 1.  Arterial thrombosis--insidious, unpredictable and deadly.

Authors:  Shaun P Jackson
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

Review 2.  Pleiotropic effects of statins.

Authors:  James K Liao; Ulrich Laufs
Journal:  Annu Rev Pharmacol Toxicol       Date:  2005       Impact factor: 13.820

Review 3.  Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol.

Authors:  James K Liao
Journal:  Am J Cardiol       Date:  2005-09-05       Impact factor: 2.778

4.  Study of V1a vasopressin receptor gene single nucleotide polymorphisms in platelet vasopressin responsiveness.

Authors:  Kazi N Hasan; Masaru Shoji; Shoji Tsutaya; Ryoko Kudo; Eriko Matsuda; Junko Saito; Tokihisa Kimura; Minoru Yasujima
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

5.  Relationship between serum cholesterol and indices of erythrocytes and platelets in the US population.

Authors:  Michael B Fessler; Kathryn Rose; Yanmei Zhang; Renee Jaramillo; Darryl C Zeldin
Journal:  J Lipid Res       Date:  2013-09-02       Impact factor: 5.922

Review 6.  Pleiotropic effects of statins. - Basic research and clinical perspectives -.

Authors:  Qian Zhou; James K Liao
Journal:  Circ J       Date:  2010-04-15       Impact factor: 2.993

Review 7.  An eicosanoid-centric view of atherothrombotic risk factors.

Authors:  Scott Gleim; Jeremiah Stitham; Wai Ho Tang; Kathleen A Martin; John Hwa
Journal:  Cell Mol Life Sci       Date:  2012-04-11       Impact factor: 9.261

Review 8.  [Statins for treatment of CNS diseases. Status report from research and clinical practice].

Authors:  T Menge; H-C von Büdingen; S S Zamvil; H-P Hartung; B C Kieseier; O Stüve
Journal:  Nervenarzt       Date:  2005-04       Impact factor: 1.214

9.  Alterations in the extracellular catabolism of nucleotides and platelet aggregation induced by high-fat diet in rats: effects of α-tocopherol.

Authors:  Jessié M Gutierres; Fabiano B Carvalho; Maria Rosa C Schetinger; Marília V Rodrigues; Juliano M Vieira; Paula Maldonado; Maria do Carmo S Araújo; Roberta Schmatz; Naiara Stefanello; Jeandre A S Jaques; Marcio Costa; Vera Morsch; Cinthia M Mazzanti; Victor Pimentel; Sonia Terezinha A Lopes; Roselia M Spanevello
Journal:  J Physiol Biochem       Date:  2014-03-13       Impact factor: 4.158

Review 10.  Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy.

Authors:  Qian Zhou; James K Liao
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.